Related Experiment Video
Updated: Jun 8, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation.
Luci M Dusse1, Danyelle R A Rios, Melina B Pinheiro
1Faculty of Health Sciences, University of Southampton, Southampton, UK. lucim@farmacia.ufmg.br
Summary
Pre-eclampsia, a pregnancy disorder causing hypertension, involves endothelial dysfunction. Understanding its links to haemostasis and inflammation may reveal new diagnostic and therapeutic strategies.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Medicine
- Immunology
Background:
- Pre-eclampsia (PE) is a serious pregnancy disorder defined by hypertension and proteinuria.
- Its exact cause remains unclear, but endothelial dysfunction is a key suspected factor.
- Current diagnostic and treatment options for PE are limited.
Purpose of the Study:
- To explore the potential connections between pre-eclampsia, haemostatic activation, and inflammation.
- To elucidate the pathophysiology of PE through the lens of these interactions.
- To identify potential avenues for early diagnosis and targeted therapies.
Main Methods:
- Review of existing literature on pre-eclampsia, haemostasis, and inflammation.
- Discussion of potential causal pathways linking these biological systems.
- Analysis of the implications of these interactions on PE pathogenesis.
Main Results:
- The abstract does not contain specific results but outlines a discussion of potential links.
- It highlights the need for further research into the interplay between PE, haemostasis, and inflammation.
- The review suggests these connections are crucial for understanding PE.
Conclusions:
- Understanding the relationship between pre-eclampsia, haemostasis, and inflammation is vital.
- This knowledge may lead to improved screening, diagnosis, and treatment strategies for PE.
- Further research into these interactions could pave the way for preventative measures.
Related Concept Videos
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...